Filter
1238
Text search:
drug
resistance
management
program
Featured
Recommendations
128
New Publications
403
Language
Document type
No document type
784
Studies & Reports
162
Guidelines
161
Manuals
49
Strategic & Response Plan
42
Training Material
21
Fact sheets
9
Situation Updates
7
Brochures
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
70
Kenya
51
Ethiopia
46
Tanzania
36
Uganda
32
Nepal
32
Global
31
South Africa
30
Liberia
27
Zambia
26
Latin America and the Carribbean
25
Philippines
24
Malawi
24
Sierra Leone
23
Rwanda
22
Bangladesh
21
Nigeria
20
Eastern Europe
18
Myanmar / Burma
17
Western and Central Europe
17
Zimbabwe
15
Cambodia
15
Namibia
15
Ghana
13
Indonesia
12
Asia
12
Lesotho
11
Ukraine
10
Africa
10
Mozambique
9
South–East Asia Region
8
Senegal
7
Cameroon
7
Botswana
7
Pakistan
6
Thailand
6
Russia
6
Burkina Faso
5
Congo, Democratic Republic of
5
Eswatini/ Swaziland
5
Venezuela
5
Vietnam
5
Guinea
4
USA
4
Haiti
4
West and Central Africa
4
Middle East and North Africa
4
Albania
4
Georgia
4
Afghanistan
3
Syria
3
China
3
Sri Lanka
3
Bhutan
3
Laos
3
Iran
3
North America
3
Mali
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Sudan
2
Central African Republic
2
Argentina
2
North Macedonia
2
Colombia
2
El Salvador
2
East and Southern Africa
2
Timor Leste/ East Timor
2
Tajikistan
2
Saudi Arabia
1
Somalia
1
South Sudan
1
Iraq
1
Chad
1
Benin
1
Dominican Republic
1
Peru
1
Brazil
1
Switzerland
1
Honduras
1
Ecuador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Armenia
1
Canada
1
Qatar
1
Moldova
1
Turkmenistan
1
Maldives
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
583
Clinical Guidelines
83
Public Health
56
Women & Child Health
29
Key Resources
29
Capacity Building
16
Pharmacy & Technologies
16
Toolboxes
TB
189
HIV
140
AMR
128
Mental Health
50
NTDs
37
Malaria
32
Pharmacy
31
COVID-19
21
Caregiver
20
Planetary Health
17
NCDs
17
Rapid Response
14
Ebola & Marburg
12
Health Financing Toolbox
10
2.0 Rapid Response
9
Conflict
7
Cholera
6
Polio
6
Disability
4
Natural Hazards
4
Refugee
4
Global Health Education
4
Zika
3
Social Ethics
1
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
The framework is to be used as a reference guide, applied according to local priorities and needs, and targeted at academic institutions, educators, accreditation bodies, regulatory agencies and other users. The ultimate aim is to ensure that all health workers are equipped with the requisite compet
...
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
AMR is one of the Key priority of the global health security agenda action package, as well as it is one of the commitments of Ministry of Public Health Afghanistan to combat AMR. In Afghanistan because of war and some other political issues the borders of the country are not well secured and well c
...
Assessment in action series
Key Findings from Azerbaijan, Georgia, Kyrgyzstan, Russia, and Ukraine
Writing by Katya Burns
Editing by Paul Silva and Roxanne Saucier
Kenya: Guidelines on use of antiretroviral drugs for treating and preventing HIV infection
recommended
2018 Edition
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti
...